Algert Global’s Ascendis Pharma A/S ASND Stock Holding History

Algert Global’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,175	Closed	-$375K	–	1130
2025 Q2	$375K	Sell	2,175 -374	-15%	-$60.9K	0.01%	991
2025 Q1	$397K	Buy	+2,549	New	+$364K	0.01%	956
2024 Q3	–	Sell	-2,180	Closed	-$297K	–	1198
2024 Q2	$297K	Buy	2,180 +770	+55%	+$105K	0.01%	1125
2024 Q1	$213K	Buy	+1,410	New	+$201K	0.01%	963
2023 Q2	–	Sell	-2,779	Closed	-$298K	–	1088
2023 Q1	$298K	Buy	+2,779	New	+$318K	0.01%	952
2021 Q1	–	Sell	-7,560	Closed	-$1.26M	–	436
2020 Q4	$1.26M	Sell	7,560 -1,628	-18%	-$269K	0.36%	99
2020 Q3	$1.42M	Buy	9,188 +1,394	+18%	+$200K	0.45%	73
2020 Q2	$1.15M	Sell	7,794 -2,712	-26%	-$372K	0.39%	85
2020 Q1	$1.18M	Buy	+10,506	New	+$1.37M	0.5%	55

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Algert Global's ASND Position: Q3 2025 in Review

Algert Global sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 2,175 shares — an estimated $375K sold.

Algert Global first reported a position in ASND in Q1 2020 and held it in 9 quarters. The position peaked at $1.42M in Q3 2020. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

Algert Global reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
Algert Global sold 2,175 Ascendis Pharma A/S shares in Q3 2025, an estimated $375K.
Algert Global first reported a position in Ascendis Pharma A/S in Q1 2020 and held it in 9 quarters.
Algert Global's Ascendis Pharma A/S position peaked at $1.42M in Q3 2020.
279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Algert Global's 13F filing for Q3 2025, filed 14 Nov 2025.